188 related articles for article (PubMed ID: 6936982)
21. Frequency of sensitization to different pollen groups and results of specific immunotherapy.
Martín-Gil D; Neffen H; Oehling A
Allergol Immunopathol (Madr); 1978; 6(4):325-32. PubMed ID: 735982
[TBL] [Abstract][Full Text] [Related]
22. [Pre-seasonal treatment of hayfever with a pollen depot extract (author's transl)].
Düngemann H; von Mayenburg J; Rakoski J
Med Klin; 1977 Jun; 72(24):1071-9. PubMed ID: 882040
[TBL] [Abstract][Full Text] [Related]
23. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
Williams A; Henzgen M; Rajakulasingam K
Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):123-6. PubMed ID: 17523386
[TBL] [Abstract][Full Text] [Related]
24. Species specific grass pollen sensitivity: diagnosis and treatment with single grass species Allpyral vaccines.
Brown HM; Thantrey N; Jackson F
Clin Allergy; 1979 Sep; 9(5):465-72. PubMed ID: 498489
[TBL] [Abstract][Full Text] [Related]
25. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
[TBL] [Abstract][Full Text] [Related]
26. [Specific desensitization of pollinosis by various allergen extracts (author's transl)].
Schuchardt P; Hühnerfuss S
Z Erkr Atmungsorgane; 1976 Aug; 146(2):115-9. PubMed ID: 828359
[TBL] [Abstract][Full Text] [Related]
27. Leukocyte histamine release and humoral changes during oral and subcutaneous hyposensitization of grass pollen allergic children.
Wahn U; Maasch HJ; Geissler W
Helv Paediatr Acta; 1984 May; 39(2):137-44. PubMed ID: 6085730
[TBL] [Abstract][Full Text] [Related]
28. [Pollinosis. II. Specific hyposensitization: indications and results of treatment. A study with the allergen preparation Stallergenes-Depot in the pollen season of 1976, 1977 and 1978].
Wüthrich B; Häfner G
Schweiz Med Wochenschr; 1980 Feb; 110(8):281-90. PubMed ID: 7367848
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy for grass pollenosis with allpyral allergen extracts. Improved results by objective control of treatment requirements.
Brown HM; McIntyre D
Acta Allergol; 1977 Oct; 32(5):321-32. PubMed ID: 579045
[TBL] [Abstract][Full Text] [Related]
30. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
31. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
Dahl R; Stender A; Rak S
Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspective.
Bachert C; Vestenbaek U; Christensen J; Griffiths UK; Poulsen PB
Clin Exp Allergy; 2007 May; 37(5):772-9. PubMed ID: 17456225
[TBL] [Abstract][Full Text] [Related]
33. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
[TBL] [Abstract][Full Text] [Related]
34. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
[TBL] [Abstract][Full Text] [Related]
35. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.
Walker SM; Pajno GB; Lima MT; Wilson DR; Durham SR
J Allergy Clin Immunol; 2001 Jan; 107(1):87-93. PubMed ID: 11149996
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F
J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937
[TBL] [Abstract][Full Text] [Related]
38. [Short-term immunotherapy--a survey of current studies].
Rasp G; Klimek L
Wien Med Wochenschr; 1999; 149(14-15):403-9. PubMed ID: 10584283
[TBL] [Abstract][Full Text] [Related]
39. Grass pollen specific sublingual/swallow immunotherapy in children: open-controlled comparison among different treatment protocols.
Di Rienzo V; Puccinelli P; Frati F; Parmiani S
Allergol Immunopathol (Madr); 1999; 27(3):145-51. PubMed ID: 10431100
[TBL] [Abstract][Full Text] [Related]
40. The use of grass pollen-specific immunotherapy among grass pollen allergic rhinitis in the general population.
Linneberg A; Bødtger U
Allergy; 2007 Jul; 62(7):825-6. PubMed ID: 17573735
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
